Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

The association of inpatient blood utilization and diagnosis-related group weight: implications for risk-adjusted benchmarking.

Metcalf RA, White SK, Potter S, Barney R, Hunter C, White M, Enniss T, Galaviz C, Reddy S, Wanner N, Schmidt RL, Blaylock R.

Transfusion. 2019 Jul;59(7):2316-2323. doi: 10.1111/trf.15343. Epub 2019 May 20.

PMID:
31106447
2.

Response to random apheresis platelets versus HLA-selected platelets versus pooled platelets in HLA-sensitized patients.

Gavva C, Barroso J, Gernsheimer T, Metcalf RA, Warner P, Pagano MB.

Transfusion. 2019 Jul;59(7):2276-2281. doi: 10.1111/trf.15333. Epub 2019 Apr 29.

PMID:
31032968
3.

Severe intravascular hemolysis following extracorporeal right ventricular assist device placement.

Metcalf RA, Calvaresi E, Tonna JE, Blaylock R, Pearson L.

Transfusion. 2019 Apr;59(4):1178-1179. doi: 10.1111/trf.15136. No abstract available.

PMID:
30950087
4.

Evaluating safety and cost-effectiveness of platelets stored in additive solution (PAS-F) as a hemolysis risk mitigation strategy.

Pagano MB, Katchatag BL, Khoobyari S, Van Gerwen M, Sen N, Rebecca Haley N, Gernsheimer TB, Hess JR, Metcalf RA.

Transfusion. 2019 Apr;59(4):1246-1251. doi: 10.1111/trf.15138. Epub 2018 Dec 27.

PMID:
30592057
5.

Severe ABO Hemolytic Disease of the Newborn Requiring Exchange Transfusion.

Metcalf RA, Khan J, Andrews J, Mayock D, Billimoria Z, Pagano MB.

J Pediatr Hematol Oncol. 2019 Nov;41(8):632-634. doi: 10.1097/MPH.0000000000001248.

PMID:
30044350
6.

A data-driven patient blood management strategy in liver transplantation.

Metcalf RA, Pagano MB, Hess JR, Reyes J, Perkins JD, Montenovo MI.

Vox Sang. 2018 May 1. doi: 10.1111/vox.12650. [Epub ahead of print]

PMID:
29714029
7.

Quality Improvement After Multiple Fatal Transfusion-Transmitted Bacterial Infections.

Corean J, Al-Tigar R, Pysher T, Blaylock R, Metcalf RA.

Am J Clin Pathol. 2018 Mar 7;149(4):293-299. doi: 10.1093/ajcp/aqx167.

PMID:
29462235
8.

A high plasma: red blood cell transfusion ratio during liver transplantation is associated with decreased blood utilization.

Pagano MB, Metcalf RA, Hess JR, Reyes J, Perkins JD, Montenovo MI.

Vox Sang. 2018 Apr;113(3):268-274. doi: 10.1111/vox.12634. Epub 2018 Jan 22.

PMID:
29359471
9.

Transfusion support for transgender men of childbearing age.

Mays JA, Greene DN, Metcalf RA, Pagano MB.

Transfusion. 2018 Mar;58(3):823-825. doi: 10.1111/trf.14470. Epub 2018 Jan 7.

PMID:
29315627
10.

Quality management of a massive transfusion protocol.

Hess JR, Ramos PJ, Sen NE, Cruz-Cody VG, Tuott EE, Louzon MJ, Bulger EM, Arbabi S, Pagano MB, Metcalf RA.

Transfusion. 2018 Feb;58(2):480-484. doi: 10.1111/trf.14443. Epub 2017 Dec 13.

PMID:
29238996
11.

Building a New Transfusion Service.

Hess JR, Hayden BK, Cruz-Cody VG, Louzon MJ, Tuott EE, Sen NE, Gary R, Ramos PJ, Daniel-Johnson JA, Metcalf RA, Pagano MB.

Am J Clin Pathol. 2017 Aug 1;148(2):173-178. doi: 10.1093/ajcp/aqx057.

PMID:
28898986
12.

Transportation Cooler Interventions Reduce Plasma and RBC Product Wastage.

Metcalf RA, Baker SA, Goodnough LT, Shah N.

Am J Clin Pathol. 2016 Jul;146(1):18-24. doi: 10.1093/ajcp/aqw082. Epub 2016 Jun 29. Review.

PMID:
27357292
13.

Clinical Pattern in Hypotensive Transfusion Reactions.

Metcalf RA, Bakhtary S, Goodnough LT, Andrews J.

Anesth Analg. 2016 Aug;123(2):268-73. doi: 10.1213/ANE.0000000000001387.

PMID:
27284999
14.

Immunoarchitectural patterns of progressive transformation of germinal centers with and without nodular lymphocyte-predominant Hodgkin lymphoma.

Hartmann S, Winkelmann R, Metcalf RA, Treetipsatit J, Warnke RA, Natkunam Y, Hansmann ML.

Hum Pathol. 2015 Nov;46(11):1655-61. doi: 10.1016/j.humpath.2015.07.006. Epub 2015 Jul 21.

PMID:
26410017
15.

Large B-cell lymphoma with T-cell-rich background and nodules lacking follicular dendritic cell meshworks: description of an insufficiently recognized variant.

Treetipsatit J, Metcalf RA, Warnke RA, Natkunam Y.

Hum Pathol. 2015 Jan;46(1):74-83. doi: 10.1016/j.humpath.2014.09.009. Epub 2014 Oct 8.

PMID:
25456392
16.

Myeloid cell nuclear differentiation antigen is expressed in a subset of marginal zone lymphomas and is useful in the differential diagnosis with follicular lymphoma.

Metcalf RA, Monabati A, Vyas M, Roncador G, Gualco G, Bacchi CE, Younes SF, Natkunam Y, Freud AG.

Hum Pathol. 2014 Aug;45(8):1730-6. doi: 10.1016/j.humpath.2014.04.004. Epub 2014 Apr 24.

PMID:
24925224
17.

Intravascular ALK-negative anaplastic large cell lymphoma with localized cutaneous involvement and an indolent clinical course: toward recognition of a distinct clinicopathologic entity.

Metcalf RA, Bashey S, Wysong A, Kim J, Kim YH, Gratzinger D.

Am J Surg Pathol. 2013 Apr;37(4):617-23. doi: 10.1097/PAS.0b013e318280aa9c.

PMID:
23480896
18.

Cyclin D3 coordinates the cell cycle during differentiation to regulate erythrocyte size and number.

Sankaran VG, Ludwig LS, Sicinska E, Xu J, Bauer DE, Eng JC, Patterson HC, Metcalf RA, Natkunam Y, Orkin SH, Sicinski P, Lander ES, Lodish HF.

Genes Dev. 2012 Sep 15;26(18):2075-87. doi: 10.1101/gad.197020.112. Epub 2012 Aug 28.

19.

Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes.

Metcalf RA, Zhao S, Anderson MW, Lu ZS, Galperin I, Marinelli RJ, Cherry AM, Lossos IS, Natkunam Y.

Mod Pathol. 2010 Mar;23(3):420-33. doi: 10.1038/modpathol.2009.173. Epub 2010 Jan 8.

20.

Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice.

Raveche ES, Salerno E, Scaglione BJ, Manohar V, Abbasi F, Lin YC, Fredrickson T, Landgraf P, Ramachandra S, Huppi K, Toro JR, Zenger VE, Metcalf RA, Marti GE.

Blood. 2007 Jun 15;109(12):5079-86. Epub 2007 Mar 9.

21.

Requirement for increased IL-10 in the development of B-1 lymphoproliferative disease in a murine model of CLL.

Ramachandra S, Metcalf RA, Fredrickson T, Marti GE, Raveche E.

J Clin Invest. 1996 Oct 15;98(8):1788-93.

22.

The natural history of a lymphoproliferative disorder in aged NZB mice.

Marti GE, Metcalf RA, Raveche E.

Curr Top Microbiol Immunol. 1995;194:117-26.

PMID:
7895486
23.

p53 mutations in lung cancers from Japanese mustard gas workers.

Takeshima Y, Inai K, Bennett WP, Metcalf RA, Welsh JA, Yonehara S, Hayashi Y, Fujihara M, Yamakido M, Akiyama M, et al.

Carcinogenesis. 1994 Oct;15(10):2075-9.

PMID:
7955036
24.

p53 protein accumulates frequently in early bronchial neoplasia.

Bennett WP, Colby TV, Travis WD, Borkowski A, Jones RT, Lane DP, Metcalf RA, Samet JM, Takeshima Y, Gu JR, et al.

Cancer Res. 1993 Oct 15;53(20):4817-22.

25.

p53 mutations in human immortalized epithelial cell lines.

Lehman TA, Modali R, Boukamp P, Stanek J, Bennett WP, Welsh JA, Metcalf RA, Stampfer MR, Fusenig N, Rogan EM, et al.

Carcinogenesis. 1993 May;14(5):833-9. Erratum in: Carcinogenesis 1993 Jul;14(7):1491.

PMID:
8504475
26.

p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines.

Hsu IC, Tokiwa T, Bennett W, Metcalf RA, Welsh JA, Sun T, Harris CC.

Carcinogenesis. 1993 May;14(5):987-92.

PMID:
8389256
27.

p53 mutation and protein accumulation during multistage human esophageal carcinogenesis.

Bennett WP, Hollstein MC, Metcalf RA, Welsh JA, He A, Zhu SM, Kusters I, Resau JH, Trump BF, Lane DP, et al.

Cancer Res. 1992 Nov 1;52(21):6092-7.

28.

p53 and Kirsten-ras mutations in human mesothelioma cell lines.

Metcalf RA, Welsh JA, Bennett WP, Seddon MB, Lehman TA, Pelin K, Linnainmaa K, Tammilehto L, Mattson K, Gerwin BI, et al.

Cancer Res. 1992 May 1;52(9):2610-5.

29.

Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners.

Vähäkangas KH, Samet JM, Metcalf RA, Welsh JA, Bennett WP, Lane DP, Harris CC.

Lancet. 1992 Mar 7;339(8793):576-80.

PMID:
1347094
30.

Altered p53 gene structure and expression in human epithelial cells after exposure to nickel.

Maehle L, Metcalf RA, Ryberg D, Bennett WP, Harris CC, Haugen A.

Cancer Res. 1992 Jan 1;52(1):218-21.

31.

Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer.

Bennett WP, Hollstein MC, He A, Zhu SM, Resau JH, Trump BF, Metcalf RA, Welsh JA, Midgley C, Lane DP, et al.

Oncogene. 1991 Oct;6(10):1779-84.

PMID:
1923503
32.

Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations.

Hollstein MC, Peri L, Mandard AM, Welsh JA, Montesano R, Metcalf RA, Bak M, Harris CC.

Cancer Res. 1991 Aug 1;51(15):4102-6.

33.

p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines.

Lehman TA, Bennett WP, Metcalf RA, Welsh JA, Ecker J, Modali RV, Ullrich S, Romano JW, Appella E, Testa JR, et al.

Cancer Res. 1991 Aug 1;51(15):4090-6.

34.

Biochemical and molecular epidemiology of cancer.

Sugimura H, Weston A, Caporaso NE, Shields PG, Bowman ED, Metcalf RA, Harris CC.

Biomed Environ Sci. 1991 Jun;4(1-2):73-92. Review.

PMID:
1910603
35.

Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC.

Nature. 1991 Apr 4;350(6317):427-8.

PMID:
1849234
36.

Extractable hydrocarbons and kin recognition in honeybee (Apis mellifera L.).

Page RE Jr, Metcalf RA, Metcalf RL, Erickson EH Jr, Lampman RL.

J Chem Ecol. 1991 Apr;17(4):745-56. doi: 10.1007/BF00994197.

PMID:
24258919
37.

Frequent mutation of the p53 gene in human esophageal cancer.

Hollstein MC, Metcalf RA, Welsh JA, Montesano R, Harris CC.

Proc Natl Acad Sci U S A. 1990 Dec;87(24):9958-61.

38.

Tumorigenicity of human mesothelial cell line transfected with EJ-ras oncogene.

Reddel RR, Malan-Shibley L, Gerwin BI, Metcalf RA, Harris CC.

J Natl Cancer Inst. 1989 Jun 21;81(12):945-8.

PMID:
2733039
39.

Comparison of the delayed neurotoxicity of O-methyl and O-ethyl analogs of EPN, leptophos, and cyanofenphos.

Francis BM, Hansen LG, Metcalf RA, Metcalf RL.

J Environ Sci Health B. 1982;17(6):611-33.

PMID:
7166625
40.

Cucurbitacins as kairomones for diabroticite beetles.

Metcalf RL, Metcalf RA, Rhodes AM.

Proc Natl Acad Sci U S A. 1980 Jul;77(7):3769-72.

41.

Parent--offspring conflict that is not limited by degree of kinship.

Metcalf RA, Stamps JA, Krishnan VV.

J Theor Biol. 1979 Jan 7;76(1):99-107. No abstract available.

PMID:
431090
42.

Low levels of genetic heterozygosity in hymenoptera.

Metcalf RA, Marlin JC, Whitt GS.

Nature. 1975 Oct 30;257(5529):792-4. No abstract available.

PMID:
1186862
43.

A comparative study of the effects of selective inhibitors on esterase isozymes from the mosquito Anopheles punctipennis.

Booth GM, Connor J, Metcalf RA, Larsen JR.

Comp Biochem Physiol B. 1973 Apr 15;44(4):1185-95. No abstract available.

PMID:
4123528
44.

Supplemental Content

Loading ...
Support Center